Leveraging Lessons from the Past Webinar: What's New in Quality and Regulatory? (2026)

Course overview

This webinar reviews key federal legislative and regulatory developments affecting clinical laboratories, including PAMA reimbursement reform, the Enhancing CLIA Act, the CLIA modernization RFI, termination of COVID-19 EUA authorities, and recent CLIA Memo updates. Objectives: 1. Summarize the current status of PAMA and Medicare laboratory reimbursement reforms. 2. Describe the proposed Enhancing CLIA Act and its potential impact on LDT oversight. 3. Explain the purpose and major themes of the 2026 CLIA RFI. 4. Discuss the implications of HHS terminating COVID-19 EUA declarations. 5. Identify operational and compliance impacts arising from recent CLIA memo updates.